Kolesnik, O. P., and V. O. Kuzmenko. “ERCC1 As a Marker of Prognosis and Sensitivity to Platinum-Based Chemotherapy in Patients With Stage III–IV Non-Small Cell Lung Cancer”. Pathologia, no. 1 (May 25, 2020). Accessed May 8, 2024. http://pat.zsmu.edu.ua/article/view/203639.